Factors related to survival in hepatocellular carcinoma in the geographic area of hepatocellular Sabadell geographical area;Factores relacionados con la supervivencia en el carcinoma hepatocelular en el área geográfica de Sabadell

Revista Espanola de Enfermedades Digestivas

Volumn 104, Issue 5, 2012, Pages 242-247

  Miquel, Mireia ^a,c   Sopeña, Julia ^a,c   Vergara, Mercedes ^a,c   Gil, Montserrat ^a   Casas, Meritxell ^a   Sánchez Delgado, Jorge ^a   Puig, Jordi ^b   Alguersuari, Anna ^b   Criado, Eva ^b   Dalmau, Blai ^a,c  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Servicio de Oncología Médica   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Cirrhosis; Hepatocellular carcinoma; Screening; Survival predictive factors

Indexed keywords

AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER PALLIATIVE THERAPY; CANCER PROGNOSIS; CANCER SCREENING; CANCER SURVIVAL; DISEASE COURSE; DISEASE SEVERITY; EPIDEMIOLOGICAL DATA; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HEPATITIS C; HISTOLOGY; HUMAN; IMAGING SYSTEM; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION; LIVER SURGERY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; RISK FACTOR; SPAIN; SURVIVAL PREDICTION; TUMOR VOLUME; EARLY DIAGNOSIS; LIVER TUMOR; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL;

AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; SPAIN; SURVIVAL ANALYSIS;

EID: 84867292924     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1130-01082012000500004     Document Type: Article

References (31)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55(2):74-108.
2. Colombo M, de FR, Del NE, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991;325(10):675-80.
3. Ince N, Wands JR. The increasing incidence of hepatocellular carcinoma. N Engl J Med 1999;340(10):798-9.
4. Montalto G, Cervello M, Giannitrapani L, Dantona F, Terranova A, Castagnetta LA. Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Ann N Y Acad Sci 2002;963:13-20.
5. García-Torres ML, Zaragoza A, Giner R, Primo J, del Olmo JA. Incidence and epidemiological factors of hepatocellular carcinoma in Valencia during the year 2000. Rev Esp Enferm Dig 2003;95(6):385-4.
6. Macias Rodriguez MA, Rendon UP, Tejada CM et al. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Rev Esp Enferm Dig 2000;92(7):458-69.
7. Pascual S, Irurzun J, Zapater P, et al. Usefulness of surveillance programmes for early diagnosis of hepatocellular carcinoma in clinical practice. Liver Int 2008;28(5):682-9.
8. Velazquez RF, Rodriguez M, Navascues CA, et al. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology 2003;37(3):520-7.
9. Vergara M, Gil M, Dalmau B, et al. Natural history of hepatocellular carcinoma in a cohort of pacients from a county hospital. Rev Esp Enferm Dig 2008;100(11):682-7.
10. Zapata E, Zubiaurre L, Castiella A, et al. Are hepatocellular carcinoma surveillance programs effective at improving the therapeutic options. Rev Esp Enferm Dig 2010;102(8):484-8.
11. Johnson PJ, Williams R. Cirrhosis and the aetiology of hepatocellular carcinoma. J Hepatol 1987;4(1):140-7.
12. Kew MC, Popper H. Relationship between hepatocellular carcinoma and cirrhosis. Semin Liver Dis 1984;4(2):136-46.
13. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362(9399):1907-17.
14. Llovet JM, Bruix J. Novel advancements in the management of hepatocellular carcinoma 2008. J Hepatol 2008;48(Supl. 1):S20-S37.
15. Cottone M, Turri M, Caltagirone M, et al. Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8-year prospective study by ultrasound and alphafetoprotein. J Hepatol 1994;21(6):1029-34.
16. Pateron D, Ganne N, Trinchet JC, et al. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol 1994;20(1):65-71.
17. Bosetti C, Levi F, Boffeta P, Lucchini F, Negri E, La V. Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004. Hepatology 2008;48:137-45.
18. Sort P, Alvarez MA, Bargallo A, et al. Cost of screening for hepatocarcinoma in patients with cirrhosis: a prospective study. Gastroenterol Hepatol 2011;34(8):519-23.
19. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005;42(5):1208-36.
20. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002;35(3):519-24.
21. Llovet JM, Schwartz M, Mazzaferro V. Resection and liver trasplantation for hepatocellular carcinoma. Semin Liver Dis 2005;25:181-200.
22. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60(8):646-9.
23. Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124(1):91-6.
24. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35(3):421-30.
25. Trinchet JC, Ganne-Carrie N, Nahon P, N'kontchou G, Beaugrand M. Hepatocellular carcinoma in patients with hepatitis C virus-related chronic liver disease. World J Gastroenterol 2007;13:2455-60.
26. Calvet X, Bruix J, Bru C, et al. Natural history of hepatocellular carcinoma in Spain. Five year's experience in 249 cases. J Hepatol 1990; 10:311-7.
27. Tyson GL, Duan Z, Kramer JR, Davila JA, Richardson PA, El-Serag HB. Level of alpha-fetoprotein predicts mortality among patients with hepatitis C-related hepatocellular carcinoma. Clin Gastroenterol Hepatol 2011;9(11):989-94.
28. Forner A, Vilana R, Ayuso C, et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 2008; 47:97-104.
29. Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004; 130:417-22.
30. Trevisani F, Santi V, Gramenzi A, et al. Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis? Am J Gastroenterol 2007;102:2448-57.
31. Marrero JA, Kudo M, Bronowicki JP. The challenge of prognosis and staging for hepatocellular carcinoma. Oncologist 2010;15 (Supl. 4):23-33.